| 亞洲大學 |
2015 |
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
|
Lin, Meng-Ju Li；Meng-Ju Li；Yung-Li Yang；Yung-Li Yang；Ni-Chung Lee；Ni-Chung Lee；Shiann-Tarng；Shiann-Tarng Jou；Meng-Yao Lu；Meng-Yao Lu；Hsiu-Hao Cha；Hsiu-Hao Chang；Kai-Hsin Lin；Kai-Hsin Lin；彭慶添；Dong-Tsamn L；Dong-Tsamn |
| 亞洲大學 |
2015 |
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
|
Li), Meng-Ju Li(Meng-Ju;Yang), Yung-Li Yang(Yung-Li;Lee), Ni-Chung Lee(Ni-Chung;Jou), Shiann-Tarng(Shiann-Tarng;Lu), Meng-Yao Lu(Meng-Yao;Chang), Hsiu-Hao Cha(Hsiu-Hao;Lin), Kai-Hsin Lin(Kai-Hsin;彭慶添*;Lin), Dong-Tsamn L(Dong-Tsamn |
| 國立臺灣大學 |
2016 |
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
|
Li, Meng-Ju; Yang, Yung-Li; Lee, Ni-Chung; Jou, Shiann-Tarng; Lu, Meng-Yao; Chang, Hsiu-Hao; Lin, Kai-Hsin; Peng, Ching-Tien; Lin, Dong-Tsamn; 李孟儒; 林東燦; 周獻堂; 李妮鍾; 盧孟佑; 張修豪; 林凱信; 楊永立 |
| 中國醫藥大學 |
2015-09 |
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
|
李孟如(Meng-Ju Li);楊永立(Yung-Li Yang);李妮鐘(Ni-Chung Lee);周獻堂(Shiann-Tarng Jou);盧孟佑(Meng-Yao Lu);張修豪(Hsiu-Hao Chang);林凱信(Kai-Hsin Lin);彭慶添(Ching-Tien Peng)*;林東燦(Dong-Tsamn Lin)* |
| 臺大學術典藏 |
2020-12-09T01:38:21Z |
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
|
Li M.-J.; Yang Y.-L.; NI-CHUNG LEE; Jou S.-T.; Lu M.-Y.; Chang H.-H.; Lin K.-H.; Peng C.-T.; Lin D.-T. |
| 臺大學術典藏 |
2020-12-09T02:07:52Z |
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
|
MENG-JU LI; Yang Y.-L.; Lee N.-C.; Jou S.-T.; Lu M.-Y.; Chang H.-H.; Lin K.-H.; Peng C.-T.; Lin D.-T. |
| 臺大學術典藏 |
2020-12-16T07:21:51Z |
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
|
Li M.-J.; Yang Y.-L.; Lee N.-C.; Jou S.-T.; MENG-YAO LU; Chang H.-H.; Lin K.-H.; Peng C.-T.; Lin D.-T. |
| 臺大學術典藏 |
2020-12-18T05:28:40Z |
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
|
Lu M.-Y.; Jou S.-T.; Li M.-J.; Yang Y.-L.; Lee N.-C.; HSIU-HAO CHANG; Lin K.-H.; Peng C.-T.; Lin D.-T. |
| 臺大學術典藏 |
2016 |
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
|
Lin D.-T.; Li M.-J.; Yang Y.-L.; Lee N.-C.; SHIANN-TANG JOU; Lu M.-Y.; Chang H.-H.; Lin K.-H.; Peng C.-T. |
| 臺大學術典藏 |
2021-01-06T03:39:00Z |
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
|
Li M.-J.; YUNG-LI YANG; Lee N.-C.; Jou S.-T.; Lu M.-Y.; Chang H.-H.; Lin K.-H.; Peng C.-T.; Lin D.-T. |
| 國立臺灣大學 |
2014 |
TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator
|
Tsai, Ya-Ping; Chen, Hsiao-Fan; Chen, Sung-Yuan; Cheng, Wei-Chung; Wang, Hsei-Wei; Shen, Zih-Jie; Song, Chunxiao; Teng, Shu-Chun; He, Chuan; Wu, Kou-Juey; 鄧述諄 |
| 中國醫藥大學 |
2014-12 |
TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator
|
蔡雅萍(Ya-Ping Tsai);陳筱凡(Hsiao-Fan Chen);陳松遠(Sung-Yuan Chen);鄭維中;王學偉(Hsei-Wei Wang);沈子傑(Zih-Jie Shen);(Chunxiao Song);鄧述諄(Shu-Chun Teng);(Chuan He);吳國瑞(Kou-Juey Wu)* |
| 臺大學術典藏 |
2022-04-15T03:14:23Z |
TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator
|
Kao L.; Wang Y.-T.; Chen Y.-C.; Tseng S.-F.; Jhang J.-C.; Chen Y.-J.; SHU-CHUN TENG |
| 國立交通大學 |
2014-12-08T15:28:20Z |
TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
|
Hsu, Chih-Hung; Peng, Kai-Lin; Kang, Ming-Lun; Chen, Yi-Ren; Yang, Yu-Chih; Tsai, Chin-Hsien; Chu, Chi-Shuen; Jeng, Yung-Ming; Chen, Yen-Ting; Lin, Feng-Mao; Huang, Hsien-Da; Lu, Yun-Yuh; Teng, Yu-Ching; Lin, Shinn-Tsuen; Lin, Ruo-Kai; Tang, Fan-Mei; Lee, Sung-Bau; Hsu, Huan Ming; Yu, Jyh-Cherng; Hsiao, Pei-Wen; Juan, Li-Jung |
| 臺大學術典藏 |
2018-09-10T09:22:39Z |
TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
|
Hsu, C.-H. and Peng, K.-L. and Kang, M.-L. and Chen, Y.-R. and Yang, Y.-C. and Tsai, C.-H. and Chu, C.-S. and Jeng, Y.-M. and Chen, Y.-T. and Lin, F.-M. and Huang, H.-D. and Lu, Y.-Y. and Teng, Y.-C. and Lin, S.-T. and Lin, R.-K. and Tang, F.-M. and Lee, S.-B. and Hsu, H. and Yu, J.-C. and Hsiao, P.-W. and Juan, L.-J.; YUNG-MING JENG; CHIH-HUNG HSU |
| 臺大學術典藏 |
2020-03-06T08:25:13Z |
TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
|
Huang H.-D.; Lu Y.-Y.; Teng Y.-C.; Lin S.-T.; Lin R.-K.; Tang F.-M.; Lee S.-B.; Hsu H.; Yu J.-C.; Hsiao P.-W.; Juan L.-J.; Lin F.-M.; Chen Y.-T.; YUNG-MING JENG; Chu C.-S.; Tsai C.-H.; Yang Y.-C.; Chen Y.-R.; Kang M.-L.; Peng K.-L.; Hsu C.-H. |
| 國家衛生研究院 |
2015-08 |
TET1-mediated epigenetic reprogramming switches metabolism and promotes malignant phenotypes of ovarian cancer
|
Chen, LY;Huang, RL;Yan, PS;Huang, TS;Liao, YP;Chou, JL;Lin, JMJ;Chao, TK;Chan, MWY;Chang, WSW;Lai, HC |
| 國立臺灣大學 |
2015 |
Tet1和5-hydroxymethylcytosine在淋巴生發中心的形成和功能的角色
|
楊楚光; Yang, Chu-Kuang |
| 國立臺灣大學 |
2015 |
TET2 ALTERATIONS IN TAIWANESE CHILDHOOD ACUTE MYELOID LEUKEMIA
|
Li, M. J.; Lin, D. T.; Tsai, F. J.; Tsai, C. H.; Peng, C. T.; 李孟儒; 林東燦 |
| 臺大學術典藏 |
2021-01-05T00:56:38Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Kuo Y.-Y.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Tsay W.; Yao M.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu C.-W.; Kuo K.-T.; Lee F.-Y.; Liu M.-C. |
| 臺大學術典藏 |
2011 |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Liu C.-Y.; SHENG-CHIEH CHOU; Chou W.-C.; Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Kuo K.-T.; Kuo Y.-Y.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y. |
| 臺大學術典藏 |
2021-01-06T03:58:39Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; JIH-LUH TANG; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:22Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; SZU-CHUN HSU; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2011 |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu C.-W.; Lee F.-Y.; Liu M.-C.; Chou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; SHANG-YI HUANG; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T. |
| 臺大學術典藏 |
2022-01-12T07:07:38Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; HSIN-AN HOU; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
